ラクオリア創薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/25 | 1,031 | 1,053 | 1,020 | 1,041 | -7 | -0.7% | 226,900 |
| 2023/01/24 | 1,078 | 1,081 | 1,045 | 1,048 | -37 | -3.4% | 425,100 |
| 2023/01/23 | 1,076 | 1,111 | 1,060 | 1,085 | +2 | +0.2% | 598,400 |
| 2023/01/20 | 1,131 | 1,132 | 1,074 | 1,083 | -105 | -8.8% | 1,015,500 |
| 2023/01/19 | 1,158 | 1,213 | 1,122 | 1,188 | +82 | +7.4% | 2,303,300 |
| 2023/01/18 | 1,094 | 1,114 | 1,077 | 1,106 | +32 | +3% | 172,800 |
| 2023/01/17 | 1,119 | 1,119 | 1,074 | 1,074 | -33 | -3% | 250,900 |
| 2023/01/16 | 1,134 | 1,152 | 1,107 | 1,107 | -57 | -4.9% | 212,500 |
| 2023/01/13 | 1,182 | 1,183 | 1,161 | 1,164 | -21 | -1.8% | 96,300 |
| 2023/01/12 | 1,191 | 1,195 | 1,178 | 1,185 | -10 | -0.8% | 60,500 |
| 2023/01/11 | 1,181 | 1,214 | 1,180 | 1,195 | +39 | +3.4% | 166,700 |
| 2023/01/10 | 1,199 | 1,209 | 1,151 | 1,156 | -48 | -4% | 175,300 |
| 2023/01/06 | 1,169 | 1,209 | 1,169 | 1,204 | +19 | +1.6% | 147,400 |
| 2023/01/05 | 1,211 | 1,217 | 1,175 | 1,185 | +8 | +0.7% | 163,200 |
| 2023/01/04 | 1,234 | 1,239 | 1,177 | 1,177 | -55 | -4.5% | 176,700 |
| 2022/12/30 | 1,222 | 1,246 | 1,208 | 1,232 | +19 | +1.6% | 141,700 |
| 2022/12/29 | 1,185 | 1,224 | 1,185 | 1,213 | +16 | +1.3% | 99,700 |
| 2022/12/28 | 1,190 | 1,222 | 1,168 | 1,197 | -9 | -0.7% | 218,200 |
| 2022/12/27 | 1,220 | 1,235 | 1,203 | 1,206 | +8 | +0.7% | 142,000 |
| 2022/12/26 | 1,222 | 1,222 | 1,197 | 1,198 | -16 | -1.3% | 112,100 |
| 2022/12/23 | 1,200 | 1,222 | 1,194 | 1,214 | +7 | +0.6% | 173,500 |
| 2022/12/22 | 1,250 | 1,250 | 1,206 | 1,207 | -43 | -3.4% | 247,000 |
| 2022/12/21 | 1,250 | 1,265 | 1,235 | 1,250 | +15 | +1.2% | 148,000 |
| 2022/12/20 | 1,300 | 1,300 | 1,220 | 1,235 | -61 | -4.7% | 401,500 |
| 2022/12/19 | 1,332 | 1,336 | 1,288 | 1,296 | -39 | -2.9% | 231,600 |
| 2022/12/16 | 1,359 | 1,364 | 1,333 | 1,335 | -32 | -2.3% | 189,300 |
| 2022/12/15 | 1,357 | 1,374 | 1,342 | 1,367 | +9 | +0.7% | 137,700 |
| 2022/12/14 | 1,399 | 1,414 | 1,358 | 1,358 | -39 | -2.8% | 261,900 |
| 2022/12/13 | 1,417 | 1,421 | 1,385 | 1,397 | +4 | +0.3% | 236,700 |
| 2022/12/12 | 1,375 | 1,414 | 1,371 | 1,393 | +6 | +0.4% | 210,100 |
| 2022/12/09 | 1,354 | 1,396 | 1,339 | 1,387 | +41 | +3% | 254,500 |
| 2022/12/08 | 1,359 | 1,359 | 1,334 | 1,346 | -9 | -0.7% | 116,800 |
| 2022/12/07 | 1,327 | 1,355 | 1,312 | 1,355 | +18 | +1.3% | 247,700 |
| 2022/12/06 | 1,339 | 1,350 | 1,333 | 1,337 | -2 | -0.1% | 143,200 |
| 2022/12/05 | 1,340 | 1,360 | 1,324 | 1,339 | -4 | -0.3% | 205,900 |
| 2022/12/02 | 1,338 | 1,355 | 1,319 | 1,343 | +3 | +0.2% | 139,600 |
| 2022/12/01 | 1,355 | 1,364 | 1,329 | 1,340 | -6 | -0.4% | 175,800 |
| 2022/11/30 | 1,365 | 1,367 | 1,334 | 1,346 | -30 | -2.2% | 237,500 |
| 2022/11/29 | 1,353 | 1,390 | 1,340 | 1,376 | +33 | +2.5% | 317,300 |
| 2022/11/28 | 1,326 | 1,362 | 1,319 | 1,343 | +7 | +0.5% | 206,300 |
| 2022/11/25 | 1,331 | 1,347 | 1,312 | 1,336 | -3 | -0.2% | 226,600 |
| 2022/11/24 | 1,331 | 1,346 | 1,325 | 1,339 | +1 | +0.1% | 186,700 |
| 2022/11/22 | 1,319 | 1,358 | 1,309 | 1,338 | +28 | +2.1% | 305,700 |
| 2022/11/21 | 1,340 | 1,342 | 1,290 | 1,310 | -75 | -5.4% | 761,500 |
| 2022/11/18 | 1,375 | 1,400 | 1,304 | 1,385 | +155 | +12.6% | 1,971,900 |
| 2022/11/17 | 1,266 | 1,274 | 1,221 | 1,230 | -51 | -4% | 282,300 |
| 2022/11/16 | 1,290 | 1,305 | 1,269 | 1,281 | -11 | -0.9% | 291,700 |
| 2022/11/15 | 1,236 | 1,295 | 1,228 | 1,292 | +56 | +4.5% | 494,000 |
| 2022/11/14 | 1,125 | 1,258 | 1,118 | 1,236 | +126 | +11.4% | 911,400 |
| 2022/11/11 | 1,126 | 1,129 | 1,102 | 1,110 | -8 | -0.7% | 139,700 |
451～
500
件表示中 / 3268件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ラクオリア | 46,200円 | +138.6% | - | 0.00% | 42.35倍 | 1.78倍 |
|
ファイザー旧国内研究所が前身。導出した発売済み消化器薬等収益柱に成長、低分子創薬に強い |
| ソレイジア | 5,000円 | +102.6% | - | 0.00% | - | 5.54倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
| ペルセウス | 72,300円 | 0.0% | - | 0.00% | - | 6.06倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体（ＡＤＣ）開発 |
| モダリス | 14,100円 | - | - | 0.00% | - | 8.93倍 |
|
遺伝子治療薬の創薬ベンチャー、切断しない独自のゲノム編集技術に強み。研究開発中心は米国 |
| 仁 丹 | 211,400円 | +2.4% | +10.4% | 2.60% | 12.36倍 | 0.69倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
市場注目の銘柄
チャート関連のコラム
